Industry Research Reports

Home > Reports > Service & Software > Global AI Drug Development Market Research Report 2024

Global AI Drug Development Market Research Report 2024

Industry: Service & Software

Published Date: 2024-01-17

Pages: 87 Pages

Report ld: 2282133

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global AI Drug Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for AI Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Development.

MARKET SEGMENTATION

By Company

Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg，Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Drug Design
Drug Synthesis
Other

Segment by Application

Tumor
Nervous System
Other

biaoTi REPORT SCOPE

The AI Drug Development market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of AI Drug Development companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Drug Development Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drug Design

1.2.3 Drug Synthesis

1.2.4 Other

1.3 Market by Application

1.3.1 Global AI Drug Development Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Tumor

1.3.3 Nervous System

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI Drug Development Market Perspective (2019-2030)

2.2 AI Drug Development Growth Trends by Region

2.2.1 Global AI Drug Development Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 AI Drug Development Historic Market Size by Region (2019-2024)

2.2.3 AI Drug Development Forecasted Market Size by Region (2025-2030)

2.3 AI Drug Development Market Dynamics

2.3.1 AI Drug Development Industry Trends

2.3.2 AI Drug Development Market Drivers

2.3.3 AI Drug Development Market Challenges

2.3.4 AI Drug Development Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Drug Development Players by Revenue

3.1.1 Global Top AI Drug Development Players by Revenue (2019-2024)

3.1.2 Global AI Drug Development Revenue Market Share by Players (2019-2024)

3.2 Global AI Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by AI Drug Development Revenue

3.4 Global AI Drug Development Market Concentration Ratio

3.4.1 Global AI Drug Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Revenue in 2023

3.5 AI Drug Development Key Players Head office and Area Served

3.6 Key Players AI Drug Development Product Solution and Service

3.7 Date of Enter into AI Drug Development Market

3.8 Mergers & Acquisitions, Expansion Plans

4 AI Drug Development Breakdown Data by Type

4.1 Global AI Drug Development Historic Market Size by Type (2019-2024)

4.2 Global AI Drug Development Forecasted Market Size by Type (2025-2030)

5 AI Drug Development Breakdown Data by Application

5.1 Global AI Drug Development Historic Market Size by Application (2019-2024)

5.2 Global AI Drug Development Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America AI Drug Development Market Size (2019-2030)

6.2 North America AI Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America AI Drug Development Market Size by Country (2019-2024)

6.4 North America AI Drug Development Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Drug Development Market Size (2019-2030)

7.2 Europe AI Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe AI Drug Development Market Size by Country (2019-2024)

7.4 Europe AI Drug Development Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI Drug Development Market Size (2019-2030)

8.2 Asia-Pacific AI Drug Development Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific AI Drug Development Market Size by Region (2019-2024)

8.4 Asia-Pacific AI Drug Development Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI Drug Development Market Size (2019-2030)

9.2 Latin America AI Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America AI Drug Development Market Size by Country (2019-2024)

9.4 Latin America AI Drug Development Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Drug Development Market Size (2019-2030)

10.2 Middle East & Africa AI Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa AI Drug Development Market Size by Country (2019-2024)

10.4 Middle East & Africa AI Drug Development Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Insilico Medicine

11.1.1 Insilico Medicine Company Detail

11.1.2 Insilico Medicine Business Overview

11.1.3 Insilico Medicine AI Drug Development Introduction

11.1.4 Insilico Medicine Revenue in AI Drug Development Business (2019-2024)

11.1.5 Insilico Medicine Recent Development

11.2 Cyclica

11.2.1 Cyclica Company Detail

11.2.2 Cyclica Business Overview

11.2.3 Cyclica AI Drug Development Introduction

11.2.4 Cyclica Revenue in AI Drug Development Business (2019-2024)

11.2.5 Cyclica Recent Development

11.3 XtalPi Inc.

11.3.1 XtalPi Inc. Company Detail

11.3.2 XtalPi Inc. Business Overview

11.3.3 XtalPi Inc. AI Drug Development Introduction

11.3.4 XtalPi Inc. Revenue in AI Drug Development Business (2019-2024)

11.3.5 XtalPi Inc. Recent Development

11.4 Exscientia Limited

11.4.1 Exscientia Limited Company Detail

11.4.2 Exscientia Limited Business Overview

11.4.3 Exscientia Limited AI Drug Development Introduction

11.4.4 Exscientia Limited Revenue in AI Drug Development Business (2019-2024)

11.4.5 Exscientia Limited Recent Development

11.5 AiCure, LLC

11.5.1 AiCure, LLC Company Detail

11.5.2 AiCure, LLC Business Overview

11.5.3 AiCure, LLC AI Drug Development Introduction

11.5.4 AiCure, LLC Revenue in AI Drug Development Business (2019-2024)

11.5.5 AiCure, LLC Recent Development

11.6 Atomwise

11.6.1 Atomwise Company Detail

11.6.2 Atomwise Business Overview

11.6.3 Atomwise AI Drug Development Introduction

11.6.4 Atomwise Revenue in AI Drug Development Business (2019-2024)

11.6.5 Atomwise Recent Development

11.7 Biovista Inc.

11.7.1 Biovista Inc. Company Detail

11.7.2 Biovista Inc. Business Overview

11.7.3 Biovista Inc. AI Drug Development Introduction

11.7.4 Biovista Inc. Revenue in AI Drug Development Business (2019-2024)

11.7.5 Biovista Inc. Recent Development

11.8 Breg，Inc.

11.8.1 Breg，Inc. Company Detail

11.8.2 Breg，Inc. Business Overview

11.8.3 Breg，Inc. AI Drug Development Introduction

11.8.4 Breg，Inc. Revenue in AI Drug Development Business (2019-2024)

11.8.5 Breg，Inc. Recent Development

11.9 Numerate

11.9.1 Numerate Company Detail

11.9.2 Numerate Business Overview

11.9.3 Numerate AI Drug Development Introduction

11.9.4 Numerate Revenue in AI Drug Development Business (2019-2024)

11.9.5 Numerate Recent Development

11.10 Cloud Pharmaceuticals

11.10.1 Cloud Pharmaceuticals Company Detail

11.10.2 Cloud Pharmaceuticals Business Overview

11.10.3 Cloud Pharmaceuticals AI Drug Development Introduction

11.10.4 Cloud Pharmaceuticals Revenue in AI Drug Development Business (2019-2024)

11.10.5 Cloud Pharmaceuticals Recent Development

11.11 IBM

11.11.1 IBM Company Detail

11.11.2 IBM Business Overview

11.11.3 IBM AI Drug Development Introduction

11.11.4 IBM Revenue in AI Drug Development Business (2019-2024)

11.11.5 IBM Recent Development

11.12 NuMedii

11.12.1 NuMedii Company Detail

11.12.2 NuMedii Business Overview

11.12.3 NuMedii AI Drug Development Introduction

11.12.4 NuMedii Revenue in AI Drug Development Business (2019-2024)

11.12.5 NuMedii Recent Development

11.13 BenevolentAI

11.13.1 BenevolentAI Company Detail

11.13.2 BenevolentAI Business Overview

11.13.3 BenevolentAI AI Drug Development Introduction

11.13.4 BenevolentAI Revenue in AI Drug Development Business (2019-2024)

11.13.5 BenevolentAI Recent Development

11.14 Lam Therapeutics

11.14.1 Lam Therapeutics Company Detail

11.14.2 Lam Therapeutics Business Overview

11.14.3 Lam Therapeutics AI Drug Development Introduction

11.14.4 Lam Therapeutics Revenue in AI Drug Development Business (2019-2024)

11.14.5 Lam Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global AI Drug Development Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drug Design

Table 3. Key Players of Drug Synthesis

Table 4. Key Players of Other

Table 5. Global AI Drug Development Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global AI Drug Development Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global AI Drug Development Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global AI Drug Development Market Share by Region (2019-2024)

Table 9. Global AI Drug Development Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global AI Drug Development Market Share by Region (2025-2030)

Table 11. AI Drug Development Market Trends

Table 12. AI Drug Development Market Drivers

Table 13. AI Drug Development Market Challenges

Table 14. AI Drug Development Market Restraints

Table 15. Global AI Drug Development Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global AI Drug Development Market Share by Players (2019-2024)

Table 17. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2023)

Table 18. Ranking of Global Top AI Drug Development Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by AI Drug Development Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players AI Drug Development Product Solution and Service

Table 22. Date of Enter into AI Drug Development Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI Drug Development Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global AI Drug Development Revenue Market Share by Type (2019-2024)

Table 26. Global AI Drug Development Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global AI Drug Development Revenue Market Share by Type (2025-2030)

Table 28. Global AI Drug Development Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global AI Drug Development Revenue Market Share by Application (2019-2024)

Table 30. Global AI Drug Development Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global AI Drug Development Revenue Market Share by Application (2025-2030)

Table 32. North America AI Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America AI Drug Development Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America AI Drug Development Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe AI Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe AI Drug Development Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe AI Drug Development Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific AI Drug Development Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific AI Drug Development Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific AI Drug Development Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America AI Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America AI Drug Development Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America AI Drug Development Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa AI Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa AI Drug Development Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa AI Drug Development Market Size by Country (2025-2030) & (US$ Million)

Table 47. Insilico Medicine Company Detail

Table 48. Insilico Medicine Business Overview

Table 49. Insilico Medicine AI Drug Development Product

Table 50. Insilico Medicine Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 51. Insilico Medicine Recent Development

Table 52. Cyclica Company Detail

Table 53. Cyclica Business Overview

Table 54. Cyclica AI Drug Development Product

Table 55. Cyclica Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 56. Cyclica Recent Development

Table 57. XtalPi Inc. Company Detail

Table 58. XtalPi Inc. Business Overview

Table 59. XtalPi Inc. AI Drug Development Product

Table 60. XtalPi Inc. Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 61. XtalPi Inc. Recent Development

Table 62. Exscientia Limited Company Detail

Table 63. Exscientia Limited Business Overview

Table 64. Exscientia Limited AI Drug Development Product

Table 65. Exscientia Limited Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 66. Exscientia Limited Recent Development

Table 67. AiCure, LLC Company Detail

Table 68. AiCure, LLC Business Overview

Table 69. AiCure, LLC AI Drug Development Product

Table 70. AiCure, LLC Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 71. AiCure, LLC Recent Development

Table 72. Atomwise Company Detail

Table 73. Atomwise Business Overview

Table 74. Atomwise AI Drug Development Product

Table 75. Atomwise Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 76. Atomwise Recent Development

Table 77. Biovista Inc. Company Detail

Table 78. Biovista Inc. Business Overview

Table 79. Biovista Inc. AI Drug Development Product

Table 80. Biovista Inc. Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 81. Biovista Inc. Recent Development

Table 82. Breg，Inc. Company Detail

Table 83. Breg，Inc. Business Overview

Table 84. Breg，Inc. AI Drug Development Product

Table 85. Breg，Inc. Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 86. Breg，Inc. Recent Development

Table 87. Numerate Company Detail

Table 88. Numerate Business Overview

Table 89. Numerate AI Drug Development Product

Table 90. Numerate Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 91. Numerate Recent Development

Table 92. Cloud Pharmaceuticals Company Detail

Table 93. Cloud Pharmaceuticals Business Overview

Table 94. Cloud Pharmaceuticals AI Drug Development Product

Table 95. Cloud Pharmaceuticals Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 96. Cloud Pharmaceuticals Recent Development

Table 97. IBM Company Detail

Table 98. IBM Business Overview

Table 99. IBM AI Drug Development Product

Table 100. IBM Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 101. IBM Recent Development

Table 102. NuMedii Company Detail

Table 103. NuMedii Business Overview

Table 104. NuMedii AI Drug Development Product

Table 105. NuMedii Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 106. NuMedii Recent Development

Table 107. BenevolentAI Company Detail

Table 108. BenevolentAI Business Overview

Table 109. BenevolentAI AI Drug Development Product

Table 110. BenevolentAI Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 111. BenevolentAI Recent Development

Table 112. Lam Therapeutics Company Detail

Table 113. Lam Therapeutics Business Overview

Table 114. Lam Therapeutics AI Drug Development Product

Table 115. Lam Therapeutics Revenue in AI Drug Development Business (2019-2024) & (US$ Million)

Table 116. Lam Therapeutics Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global AI Drug Development Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global AI Drug Development Market Share by Type: 2023 VS 2030

Figure 3. Drug Design Features

Figure 4. Drug Synthesis Features

Figure 5. Other Features

Figure 6. Global AI Drug Development Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global AI Drug Development Market Share by Application: 2023 VS 2030

Figure 8. Tumor Case Studies

Figure 9. Nervous System Case Studies

Figure 10. Other Case Studies

Figure 11. AI Drug Development Report Years Considered

Figure 12. Global AI Drug Development Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global AI Drug Development Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global AI Drug Development Market Share by Region: 2023 VS 2030

Figure 15. Global AI Drug Development Market Share by Players in 2023

Figure 16. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by AI Drug Development Revenue in 2023

Figure 18. North America AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America AI Drug Development Market Share by Country (2019-2030)

Figure 20. United States AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe AI Drug Development Market Share by Country (2019-2030)

Figure 24. Germany AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific AI Drug Development Market Share by Region (2019-2030)

Figure 32. China AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America AI Drug Development Market Share by Country (2019-2030)

Figure 40. Mexico AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa AI Drug Development Market Share by Country (2019-2030)

Figure 44. Turkey AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia AI Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Insilico Medicine Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 47. Cyclica Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 48. XtalPi Inc. Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 49. Exscientia Limited Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 50. AiCure, LLC Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 51. Atomwise Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 52. Biovista Inc. Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 53. Breg，Inc. Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 54. Numerate Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 55. Cloud Pharmaceuticals Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 56. IBM Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 57. NuMedii Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 58. BenevolentAI Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 59. Lam Therapeutics Revenue Growth Rate in AI Drug Development Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI Drug Development market? zhanKai

The top companies in the global AI Drug Development market are Insilico Medicine、Cyclica、XtalPi Inc..

Related Reports

AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Development was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 112
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2026
The global AI Drug Development market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 114
USD 2900.00
(Single User License)
Global AI Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Development market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 141
USD 4900.00
(Single User License)
Global AI Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Development market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 95
USD 4250.00
(Single User License)
AI Drug Development- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Drug Development was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 119
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2025
The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 81
USD 2900.00
(Single User License)
Global AI Drug Development Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI Drug Development Market
Published Date: 2024-04-08
Pages: 111
USD 4900.00
(Single User License)
AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Development was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 114
USD 3950.00
(Single User License)

AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Development was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 112
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2026
The global AI Drug Development market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 114
USD 2900.00 (Single User License)
Global AI Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Development market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 141
USD 4900.00 (Single User License)
Global AI Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Development market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 95
USD 4250.00 (Single User License)
AI Drug Development- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Drug Development was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 119
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2025
The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 81
USD 2900.00 (Single User License)
Global AI Drug Development Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI Drug Development Market
Published: 2024-04-08
Pages: 111
USD 4900.00 (Single User License)
AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Development was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 114
USD 3950.00 (Single User License)